Concepedia

Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection

Evelyn Shaw, Alexander Rombauts, Fé Tubau, Ariadna Padullés, Jordi Cámara, Toni Lozano, Sara Cobo‐Sacristán, Núria Sabé, Raül Rigo‐Bonnin, M.Á. Domínguez,

Journal of Antimicrobial Chemotherapy · 2017 · 158 citations · 6 references

DOIFull text

Open access

Concepts

Abstract

Vancomycin is a commonly prescribed antibiotic for the treatment of severe Gram-positive infections and is the drug of choice for severe infections caused by MRSA.

References

6

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Ryan K. Shields, M. Hong Nguyen, Liang Chen et al. · Antimicrobial Agents and Chemotherapy · 2017 · 487 citations · Full text

, , +13

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Ryan K. Shields, Brian A. Potoski, Ghady Haidar et al. · Clinical Infectious Diseases · 2016 · 428 citations · Full text

, , +17

Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015

Barbara Albiger, Corinna Glasner, Marc Struelens et al. · Eurosurveillance · 2015 · 417 citations · Full text

, , +17

Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

Steven H. Marshall, Andrea M. Hujer, Laura J. Rojas et al. · Antimicrobial Agents and Chemotherapy · 2017 · 287 citations · Full text

, , +17

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms

Elizabeth Temkin, Julián Torre‐Cisneros, Bojana Beovič et al. · Antimicrobial Agents and Chemotherapy · 2016 · 254 citations · Full text

, , +16